A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease

Clinical trial NCT00358683 · WITHDRAWN

Trial details

NCT number: NCT00358683
Sponsor: UCB Pharma
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2007-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.